Viasat, Inc. (VSAT)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,691	1,345	2,267	2,584	3,632	3,294
Market Cap Growth	19.03%	-40.65%	-12.28%	-28.84%	10.25%	47.61%
Enterprise Value	9,599	7,390	8,403	5,709	6,054	5,196
Last Close Price	27.49	10.42	18.09	33.84	48.80	48.07
PE Ratio	-	-	-	2.38	-	892.49
Forward PE	22.59	13.19	5.67	12.12	24.43	37.34
PS Ratio	0.78	0.30	0.53	1.01	1.50	1.72
PB Ratio	0.81	0.29	0.45	0.67	1.35	1.38
P/TBV Ratio	10.45	4.85	4.48	0.82	1.86	1.71
P/OCF Ratio	3.63	1.48	3.29	7.03	7.18	4.53
PEG Ratio	-	2.59	2.59	2.76	0.95	1.56
EV/Sales Ratio	2.10	1.64	1.96	2.23	2.51	2.71
EV/EBITDA Ratio	6.99	5.36	7.49	14.38	15.00	17.62
EV/EBIT Ratio	163.09	102.75	359.18	-	-	-
Debt / Equity Ratio	1.54	1.62	1.51	0.72	1.06	0.92
Debt / EBITDA Ratio	4.65	4.93	6.09	5.41	5.80	5.91
Asset Turnover	0.30	0.28	0.36	0.36	0.41	0.38
Inventory Turnover	10.03	9.90	9.90	7.87	6.40	4.30
Quick Ratio	1.61	1.39	2.19	1.85	0.81	0.76
Current Ratio	2.12	1.72	2.69	2.35	1.51	1.40
Return on Equity (ROE)	-11.50%	-10.93%	-23.45%	-6.47%	-4.01%	-3.00%
Return on Assets (ROA)	0.24%	0.28%	0.12%	-0.85%	-0.85%	-0.56%
Return on Capital (ROIC)	0.30%	0.36%	0.15%	-0.99%	-0.98%	-0.65%
Return on Capital Employed (ROCE)	0.40%	0.50%	0.20%	-	-	-
Earnings Yield	-16.22%	-42.73%	-47.15%	41.97%	-0.43%	0.11%
FCF Yield	2.39%	-9.07%	-37.55%	-30.82%	-13.35%	-3.04%
Buyback Yield / Dilution	-3.32%	-9.63%	-54.37%	-3.43%	-10.46%	-7.81%

Updated May 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q